Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 September, 2017 05:39 IST
Strides Shasun gets USFDA nod for Potassium Citrate ER tablets
Source: IRIS | 12 Sep, 2017, 10.15AM
Comments  |  Post Comment

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq.

According to IMS data, the US market for Potassium Citrate is approximately USD 110 million.

The company will be the second generic player to commercialize the product. The product, which is the first approval for an Extended Release tablet for the company, will be launched immediately.

Potassium Citrate, a urinary alkalinizing agent, is used for preventing certain types of kidney stones. It works by neutralizing some of the acid in the urine, which helps reduce the formation of crystals. 

Shares of the company gained Rs 28.7, or 3.05%, to trade at Rs 970.00. The total volume of shares traded was 46,320 at the BSE (9.58 a.m., Tuesday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Zydus, Pharm Aid enters into pact for vaccine technology in Russia - 19-Sep-2017 14:40
SBI ties up with Google on UPI-based payments app-Tez - 19-Sep-2017 10:11
Nalco inks MoU to explore possibility of forming JVC - 19-Sep-2017 10:07
Glenmark Pharma gets USFDAs final nod for Desonide ointment - 19-Sep-2017 10:04
Mahindra Lifespace Developers enters into partnership with IFC - 19-Sep-2017 10:01
Infosys enters into 7-year partnership with CMA CGM Group - 19-Sep-2017 09:54
Vascon Engineers receives LoA worth Rs 2.35 bn - 18-Sep-2017 13:43
Punj Lloyd bags order worth Rs 1.2 bn from Govt. of India - 18-Sep-2017 12:13
Alkem Laboratories intimates of USFDA inspection at Baddi facility - 18-Sep-2017 10:45
Wipro selected as strategic partner for data center services by Innogy - 18-Sep-2017 10:35
Zydus arm gets USFDAs final nod for Oseltamivir powder - 18-Sep-2017 10:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer